Cargando…
Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
Autores principales: | Chen, Minting, Zhong, Keying, Tan, Jincheng, Meng, Mingjing, Liu, Chok Mei, Chen, Baisen, Huang, Chunhua, Wong, Hoi Leong Xavier, Bian, Zhaoxiang, Su, Tao, Kwan, Hiu Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567042/ https://www.ncbi.nlm.nih.gov/pubmed/34841696 http://dx.doi.org/10.1002/ctm2.564 |
Ejemplares similares
-
Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin–proteasome pathway
por: Gong, Rui-Hong, et al.
Publicado: (2022) -
Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis
por: Chen, Minting, et al.
Publicado: (2021) -
Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
por: Hu, Xianjing, et al.
Publicado: (2021) -
The impact of obesity on adipocyte-derived extracellular vesicles
por: Kwan, Hiu Yee, et al.
Publicado: (2021) -
TLR-4 and VEGF Polymorphisms in Chronic Periaortitis
por: Atzeni, Fabiola, et al.
Publicado: (2013)